Skip to main content

Postoperative Care of Heart Transplant Patients

  • Chapter
  • First Online:
  • 2346 Accesses

Abstract

Postoperative care of heart transplant patients includes early postoperative care and long-term care, and complications. In the early postoperative period, care focuses on optimising hemodynamic stability and graft function, institution of immunosupression therapy, and prevention of infection. Complications during this time include bleeding and coagulopathies, primary graft failure, acute rejection, arrhythmias, and infection. Management is in intensive care, with a multidisciplinary approach involving early investigation and management of complications. In the later postoperative period, cardiac allograft vasculopathy, hypertension, renal disease, diabetes, and malignancy are the most common complications, and contribute significantly to overall transplant morbidity and mortality. Management of long-term complications includes routine screening for problems such as rejection and cardiac allograft vasculopathy, and prompt investigation of symptoms and signs consistent with complications of transplantation, to allow optimal outcomes.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Costanzo MR, Dipchand A, Starling R, et al. The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients. J Heart Lung Transplant. 2010;29(8):914–56.

    Article  PubMed  Google Scholar 

  2. Leonelli FM, Pacifico A, Young JB. Frequency and significance of conduction defects early after orthotopic heart transplantation. Am J Cardiol. 1994;73(2):175–9.

    Article  CAS  PubMed  Google Scholar 

  3. Ruygrok P, McKee A. Heart transplantation. In: Sidebotham D, editor. Cardiothoracic critical care. Philadelphia, PA: Butterworth Heinemann Elsevier; 2007.

    Google Scholar 

  4. Kieler-Jensen N, Lundin S, Ricksten SE. Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside. J Heart Lung Transplant. 1995;14(3):436–43.

    CAS  PubMed  Google Scholar 

  5. Chen EP, Bittner HB, Davis RD, Van Trigt P. Hemodynamic and inotropic effects of milrinone after heart transplantation in the setting of recipient pulmonary hypertension. J Heart Lung Transplant. 1998;17(7):669–78.

    CAS  PubMed  Google Scholar 

  6. Khan TA, Schnickel G, Ross D, et al. A prospective, randomized, crossover pilot study of inhaled nitric oxide versus inhaled prostacyclin in heart transplant and lung transplant recipients. J Thorac Cardiovasc Surg. 2009;138(6):1417–24.

    Article  CAS  PubMed  Google Scholar 

  7. Ardehali A, Hughes K, Sadeghi A, et al. Inhaled nitric oxide for pulmonary hypertension after heart transplantation. Transplantation. 2001;72(4):638–41.

    Article  CAS  PubMed  Google Scholar 

  8. Leyh RG, Kofidis T, Struber M, et al. Methylene blue: the drug of choice for catecholamine-refractory vasoplegia after cardiopulmonary bypass? J Thorac Cardiovasc Surg. 2003;125(6):1426–31.

    Article  CAS  PubMed  Google Scholar 

  9. Morales DL, Garrido MJ, Madigan JD, et al. A double-blind randomized trial: prophylactic vasopressin reduces hypotension after cardiopulmonary bypass. Ann Thorac Surg. 2003;75(3):926–30.

    Article  PubMed  Google Scholar 

  10. Holmes CL, Patel BM, Russell JA, Walley KR. Physiology of vasopressin relevant to management of septic shock. Chest. 2001;120(3):989–1002.

    Article  CAS  PubMed  Google Scholar 

  11. Myburgh JA, Finfer S, Bellomo R, et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med. 2012;367(20):1901–11.

    Article  CAS  PubMed  Google Scholar 

  12. Perner A, Haase N, Guttormsen AB, et al. Hydroxyethyl starch 130/0.42 versus Ringer’s acetate in severe sepsis. N Engl J Med. 2012;367(2):124–34.

    Article  CAS  PubMed  Google Scholar 

  13. Chowdhury AH, Cox EF, Francis ST, Lobo DN. A randomized, controlled, double-blind crossover study on the effects of 2-L infusions of 0.9% saline and plasma-lyte(R) 148 on renal blood flow velocity and renal cortical tissue perfusion in healthy volunteers. Ann Surg. 2012;256(1):18–24.

    Article  PubMed  Google Scholar 

  14. Quilley CP, Lin YS, McGiff JC. Chloride anion concentration as a determinant of renal vascular responsiveness to vasoconstrictor agents. Br J Pharmacol. 1993;108(1):106–10.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Yunos NM, et al. Association between a chloride-liberal vs. chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults. JAMA. 2012;308(15):1566–72.

    Article  CAS  PubMed  Google Scholar 

  16. Serpa-Neto A. Association between use of lung-protective ventilation with lower tidal volumes and clinical outcomes among patients without acute respiratory distress syndrome. JAMA. 2012;308(16):1651–9.

    Article  CAS  PubMed  Google Scholar 

  17. Futier E, Constantin JM, Paugam-Burtz C, et al. A trial of intraoperative low-tidal-volume ventilation in abdominal surgery. N Engl J Med. 2013;369(5):428–37.

    Article  CAS  PubMed  Google Scholar 

  18. Coffin SE, Klompas M, Classen D, et al. Strategies to prevent ventilator-associated pneumonia in acute care hospitals. Infect Control Hosp Epidemiol. 2008;29 Suppl 1:S31–40.

    PubMed  Google Scholar 

  19. Robert AM, Kramer RS, Dacey LJ, et al. Cardiac surgery-associated acute kidney injury: a comparison of two consensus criteria. Ann Thorac Surg. 2010;90(6):1939–43.

    Article  PubMed  Google Scholar 

  20. Englberger L, Suri RM, Li Z, et al. Clinical accuracy of RIFLE and Acute Kidney Injury Network (AKIN) criteria for acute kidney injury in patients undergoing cardiac surgery. Crit Care. 2011;15(1):R16.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Wijeysundera DN, Karkouti K, Dupuis JY, et al. Derivation and validation of a simplified predictive index for renal replacement therapy after cardiac surgery. JAMA. 2007;297(16):1801–9.

    Article  CAS  PubMed  Google Scholar 

  22. De Santo LS, Romano G, Amarelli C, et al. Implications of acute kidney injury after heart transplantation: what a surgeon should know. Eur J Cardiothorac Surg. 2011;40(6):1355–61.

    PubMed  Google Scholar 

  23. Martinelli SM, Patel UD, Phillips-Bute BG, et al. Trends in cardiac surgery-associated acute renal failure in the United States: a disproportionate increase after heart transplantation. Ren Fail. 2009;31(8):633–40.

    Article  PubMed  Google Scholar 

  24. Pham PT, Slavov C, Pham PC. Acute kidney injury after liver, heart, and lung transplants: dialysis modality, predictors of renal function recovery, and impact on survival. Adv Chronic Kidney Dis. 2009;16(4):256–67.

    Article  PubMed  Google Scholar 

  25. Boyle JM, Moualla S, Arrigain S, et al. Risks and outcomes of acute kidney injury requiring dialysis after cardiac transplantation. Am J Kidney Dis. 2006;48(5):787–96.

    Article  PubMed  Google Scholar 

  26. Kilic A, Allen JG, Weiss ES. Validation of the United States-derived Index for Mortality Prediction After Cardiac Transplantation (IMPACT) using international registry data. J Heart Lung Transplant. 2013;32(5):492–8.

    Article  PubMed  Google Scholar 

  27. Patel NN, Rogers CA, Angelini GD, Murphy GJ. Pharmacological therapies for the prevention of acute kidney injury following cardiac surgery: a systematic review. Heart Fail Rev. 2011;16(6):553–67.

    Article  CAS  PubMed  Google Scholar 

  28. Snydman DR, Kistler KD, Ulsh P, Bergman GE, Vensak J, Morris J. The impact of CMV prevention on long-term recipient and graft survival in heart transplant recipients: analysis of the Scientific Registry of Transplant Recipients (SRTR) database. Clin Transplant. 2011;25(4):E455–62.

    Article  PubMed  Google Scholar 

  29. Snydman DR, Limaye AP, Potena L, Zamora MR. Update and review: state-of-the-art management of cytomegalovirus infection and disease following thoracic organ transplantation. Transplant Proc. 2011;43(3 Suppl):S1–17.

    Article  PubMed  Google Scholar 

  30. Lund LH, Edwards LB, Kucheryavaya AY, et al. The Registry of the International Society for Heart and Lung Transplantation: thirtieth official adult heart transplant report—2013; focus theme: age. J Heart Lung Transplant. 2013;32(10):951–64.

    Article  PubMed  Google Scholar 

  31. Teuteberg JJ, Shullo M, Zomak R, McNamara D, McCurry K, Kormos RL. Aggressive steroid weaning after cardiac transplantation is possible without the additional risk of significant rejection. Clin Transplant. 2008;22(6):730–7.

    Article  PubMed  Google Scholar 

  32. Keogh A, Richardson M, Ruygrok P, et al. Sirolimus in de novo heart transplant recipients reduces acute rejection and prevents coronary artery disease at 2 years: a randomized clinical trial. Circulation. 2004;110(17):2694–700.

    Article  CAS  PubMed  Google Scholar 

  33. Aliabadi A, Grommer M, Zuckermann A. Is induction therapy still needed in heart transplantation? Curr Opin Organ Transplant. 2011;16(5):536–42.

    Article  CAS  PubMed  Google Scholar 

  34. Wu AH, Ballantyne CM, Short BC, et al. Statin use and risks of death or fatal rejection in the Heart Transplant Lipid Registry. Am J Cardiol. 2005;95(3):367–72.

    Article  PubMed  Google Scholar 

  35. Frohlich GM, Rufibach K, Enseleit F, et al. Statins and the risk of cancer after heart transplantation. Circulation. 2012;126(4):440–7.

    Article  PubMed  Google Scholar 

  36. Crow S, Chen D, Milano C, et al. Acquired von Willebrand syndrome in continuous-flow ventricular assist device recipients. Ann Thorac Surg. 2010;90(4):1263–9.

    Article  PubMed  Google Scholar 

  37. Al-Dadah AS, Guthrie TJ, Pasque MK, Moon MR, Ewald GA, Moazami N. Clinical course and predictors of pericardial effusion following cardiac transplantation. Transplant Proc. 2007;39(5):1589–92.

    Article  CAS  PubMed  Google Scholar 

  38. Iyer A, Kumarasinghe G, Hicks M, et al. Primary graft failure after heart transplantation. J Transplant. 2011;2011:175768.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Listijono DR, Watson A, Pye R, et al. Usefulness of extracorporeal membrane oxygenation for early cardiac allograft dysfunction. J Heart Lung Transplant. 2011;30(7):783–9.

    Article  PubMed  Google Scholar 

  40. Weis F, Beiras-Fernandez A, Kaczmarek I, et al. Levosimendan: a new therapeutic option in the treatment of primary graft dysfunction after heart transplantation. J Heart Lung Transplant. 2009;28(5):501–4.

    Article  PubMed  Google Scholar 

  41. Anderson CA, Shernan SK, Leacche M, et al. Severity of intraoperative tricuspid regurgitation predicts poor late survival following cardiac transplantation. Ann Thorac Surg. 2004;78(5):1635–42.

    Article  PubMed  Google Scholar 

  42. Jeevanandam V, Russell H, Mather P, Furukawa S, Anderson A, Raman J. Donor tricuspid annuloplasty during orthotopic heart transplantation: long-term results of a prospective controlled study. Ann Thorac Surg. 2006;82(6):2089–95.

    Article  PubMed  Google Scholar 

  43. Pavri BB, O’Nunain SS, Newell JB, Ruskin JN, William G. Prevalence and prognostic significance of atrial arrhythmias after orthotopic cardiac transplantation. J Am Coll Cardiol. 1995;25(7):1673–80.

    Article  CAS  PubMed  Google Scholar 

  44. Grant SC, Khan MA, Faragher EB, Yonan N, Brooks NH. Atrial arrhythmias and pacing after orthotopic heart transplantation: bicaval versus standard atrial anastomosis. Br Heart J. 1995;74(2):149–53.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Bouchart F, Derumeaux G, Mouton-Schleifer D, Bessou JP, Redonnet M, Soyer R. Conventional and total orthotopic cardiac transplantation: a comparative clinical and echocardiographical study. Eur J Cardiothorac Surg. 1997;12(4):555–9.

    Article  CAS  PubMed  Google Scholar 

  46. Stecker EC, Strelich KR, Chugh SS, Crispell K, McAnulty JH. Arrhythmias after orthotopic heart transplantation. J Card Fail. 2005;11(6):464–72.

    Article  PubMed  Google Scholar 

  47. Vaseghi M, Boyle NG, Kedia R, et al. Supraventricular tachycardia after orthotopic cardiac transplantation. J Am Coll Cardiol. 2008;51(23):2241–9.

    Article  PubMed  Google Scholar 

  48. Roussel MG, Gorham N, Wilson L, Mangi AA. Improving recovery time following heart transplantation: the role of the multidisciplinary health care team. J Multidiscip Healthc. 2013;22(6):293–302.

    Google Scholar 

  49. Toyoda Y, Guy TS, Kashem A. Present status and future perspectives of heart transplantation. Circ J. 2013;77(5):1097–110.

    Article  CAS  PubMed  Google Scholar 

  50. Pollack A, Nazif T, Mancini D, Weisz G. Detection and imaging of cardiac allograft vasculopathy. JACC Cardiovasc Imaging. 2013;6(5):613–23.

    Article  PubMed  Google Scholar 

  51. Taylor DO, Edwards LB, Boucek MM, et al. Registry of the International Society for Heart and Lung Transplantation: twenty-third official adult heart transplantation report—2006. J Heart Lung Transplant. 2006;25(8):869–79.

    Article  PubMed  Google Scholar 

  52. Stehlik J, Edwards LB, Kucheryavaya AY, et al. The Registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult heart transplant report—2010. J Heart Lung Transplant. 2010;29(10):1089–103.

    Article  PubMed  Google Scholar 

  53. Zimmer RJ, Lee MS. Transplant coronary artery disease. JACC Cardiovasc Interv. 2010;3(4):367–77.

    Article  PubMed  Google Scholar 

  54. Ruygrok PN, Webber B, Faddy S, Muller DW, Keogh A. Angiographic regression of cardiac allograft vasculopathy after introducing sirolimus immunosuppression. J Heart Lung Transplant. 2003;22(11):1276–9.

    Article  PubMed  Google Scholar 

  55. Mancini D, Pinney S, Burkhoff D, et al. Use of rapamycin slows progression of cardiac transplantation vasculopathy. Circulation. 2003;108(1):48–53.

    Article  CAS  PubMed  Google Scholar 

  56. Ojo AO. Renal disease in recipients of nonrenal solid organ transplantation. Semin Nephrol. 2007;27(4):498–507.

    Article  PubMed  Google Scholar 

  57. Crespo-Leiro MG, Alonso-Pulpon L, Vazquez de Prada JA, et al. Malignancy after heart transplantation: incidence, prognosis and risk factors. Am J Transplant. 2008;8(5):1031–9.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sara Jane Allen M.B.Ch.B., F.C.I.C.M. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer Science+Business Media New York

About this chapter

Cite this chapter

Allen, S.J., Sidebotham, D. (2017). Postoperative Care of Heart Transplant Patients. In: Subramaniam, K., Sakai, T. (eds) Anesthesia and Perioperative Care for Organ Transplantation. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-6377-5_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-6377-5_14

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-6375-1

  • Online ISBN: 978-1-4939-6377-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics